Introduction
Coronary artery disease (CAD) begins very early in life; [1] [2] [3] therefore, it is important to identify high-risk individuals and to initiate primary prevention in a timely manner. 4, 5 CAD is a multifactorial disorder and both genetic and environmental factors contribute to its progress. Several mechanisms have been implicated in the pathogenesis of CAD including elevated levels of plasma low-density lipoprotein cholesterol, vascular inflammation, apoptosis, subintimal infiltration of immune cells, and endothelial dysfunction. [4] [5] [6] The narrow-sense heritability of CAD is estimated to be about 40%. 7, 8 The genomic variants identified through large-scale genome-wide association studies (GWAS) account for 8.9% of CAD risk; 9 therefore, a large proportion of the underlying genetic risk remains unaccounted for. The phenomenon of missing heritability has been similarly observed with GWAS for other complex diseases 10 and it is attributed to the notion that much of the heritability of a complex trait lies in SNPs that do not reach genome-wide significance association at current sample sizes. To address this issue of missing heritability, mixed linear models (MLMs) have been used. [11] [12] [13] Unlike the univariate GWAS, MLMs quantify the overall contribution of SNPs to variation of a trait without testing the SNPs individually or setting a significance threshold level. MLMs can decompose the phenotypic variance into genetic and environmental components and estimate key parameters such as the heritability of a trait or the genetic correlations between two groups. 14, 15 However; they require knowledge of the genetic relatedness of individuals. Although acquiring such information was difficult in the past, it has become feasible with the availability of genomewide genotypes from GWAS studies. In addition, MLMs allow investigation of heritability enrichment in a subset of SNPs that are defined according to functional annotation, pathways, allele frequency, etc., and therefore provide the opportunity to leverage annotation information and genome-wide genotype data to gain insight into disease biology. 12, 16 Here, exploiting the 1000 genomes imputed data, we used the MLM approach implemented in GCTA (Genome-wide Complex Trait Analysis) software 12 to investigate the genetic architecture of CAD. We included only cases and controls that were unrelated from a genetic point of view and calculated the variance explained by genome-wide autosomal SNPs. The variance estimate is derived from the average genome-wide similarity between all pairs of individuals determined using all SNPs. Heritability is estimated when case-case pairs and control-control pairs are on average more similar across the genome than case-control pairs. We partitioned this heritability by sex, chromosome, minor allele frequency (MAF), gene modules, and SNP annotation to gain further insight into the genetic architecture of CAD.
Methods
The complete description of Methods is available in the Supplementary Note. In summary, we used the data collected from six independent cohorts of Caucasian ancestry including Ottawa Heart Genomics Study A, B & C (OHGS_A2, OHGS_B2, OHGS_C2), Cleveland Clinic Genebank (CCGB_2), Duke Cathgen Study (DUKE_2) and INTERHEART (ITH_2). DNA, and phenotypic information from these cohorts were assembled over the years by the Ottawa Heart Institute as part of a large study on the genetics of CAD. 9 In each study, SNPs with missingness > 1%, HWE (HardyWeinberg Equilibrium) P-value < 0.0001, MAF < 0.01 and samples with > 1% genotype missingness or discrepancies between the reported sex and sex determined from the X chromosome were excluded. Genotypes were prephased and followed by genotype imputation based on the 1000 genomes reference panel (Phase I; release 3). Next, we merged the post-imputed data (IMPUTE2 info > 0.4) from all six studies into a single dataset. We excluded SNPs with MAF < 1%, missing values in > 1% of individuals, or HWE P-value < 0.0001 and generated genomic relatedness matrix (GRM) from the genotype data in GCTA (v1.25). 12 We further excluded one of each pair of individuals with an estimated genetic relatedness > 0.025 and finished up with a subset of 7512 unrelated individuals compromising 4535 cases and 2977 controls. Finally, we estimated the contribution (SNP-based heritability or h 2 g ) of the GRM to phenotypic variance using MLM implemented in GCTA. 12 Furthermore, we partitioned the estimated h 2 g by sex, chromosome, MAF, gene modules and SNP annotation to investigate the genetic structure of CAD.
Results

General features
General characteristics of the subjects are shown in Supplementary ma terial online, Table S1 . The prevalence of CAD was 70% in males and 43% in females (P < 0.001, see Supplementary material online, Table S1 ). Controls were older than cases according to study protocol since controls were selected from asymptomatic elderly subjects (P < 0.001, see Supplementary material online, Table S1 ).
Using the GREML (genomic-relatedness-based restricted maximumlikelihood) approach implemented in GCTA, we estimated the proportion of variance in liability to CAD explained by common genome-wide SNPs (h 2 g ). We used the notation h 2 g (SNP-based heritability) because the estimate represents a lower bound of narrow sense heritability. It is a lower bound because only the variation due to 'additive' effect of common SNPs can be captured. We also wish to clarify, in this study the term 'heritability' means h 2 g (SNP-based heritability), unless otherwise stated. Our study was adequately powered (Power > _ 80%) to detect heritabilities as small as 0.11 ( Figure 1) at a (significance level) = 0.05. After fitting the GRM generated based on all 3 163 082 SNPs in the MLM model, we found that 22% [standard error (SE) = 3%] of liability to CAD can be explained by common autosomal SNPs (Table 1A) .
Between-sex genetic difference Sex differences have been described for almost all features of CAD (prevalence, incidence, age of onset, clinical presentation, course, response to treatment). 17 As shown in Supplementary material online, Table S1 , the sex distribution for cases and controls differed significantly (P < 0.001). We thus asked whether there is a genetic difference between females and males in liability to CAD. Table 1C ) in females, a difference that is not significant at a = 0.05. We further investigated this question using bivariate analysis, considering male cases and controls as one group and female cases and controls as the second group; these two independent groups are related through the coefficients of genetic similarity calculated from 
SNPs. This approach has been previously used to study between-sex genetic heterogeneity for human height and body mass index (BMI) 15 and to study genetic relationship between psychiatric disorders measured on different individuals. 14 After fitting our bivariate model (Eq. 7), we found that the correlation (r g ) in liabilities explained by SNPs between the sexes is 0.84 (SE = 0.2), not significantly different from 1 (P = 0.3, Table 1D ), supporting the conclusion that sex differences in CAD is not due to common SNPs on autosomal chromosomes.
Effect of population structure
To investigate the possible bias in our results due to population structure (cryptic relatedness and population stratification), we fitted a model in the form of:
where h 2 C sep ð Þ is the vector of heritabilities (partitioned by chromosomes) from the separate GREML analysis (fitting one chromosome at a time) while h 2 C joint ð Þ is the corresponding vector of heritabilities from the joint analysis (fitting all chromosomes in a single analysis) and L c is the vector of chromosomal length. The above equation is based on the notion that population structure in the data causes correlations of SNPs on different chromosomes. Consequently, fitting only one chromosome in the model (separate analysis) also captures some of the variance due to other chromosomes, so that the estimate of variance explained by each chromosome from the separate analysis h 2 C sep ð Þ is biased upwards in the presence of population structure. 13 ) and 3.3e -6 (SE = 4.5e -6 ) respectively, indicating that population structure was appropriately controlled in our dataset (Figure 2A) . Of note, our genome-wide genotypes explain 26% (SE = 2%) of liability to CAD in the presence of cryptic relatedness (without excluding the related individuals), 24% (SE = 3%) in the presence of population stratification (without adjustment for the principal components of ancestry) and 28% (SE = 2%) in presence of both cryptic relatedness and population stratification (see Supplementary material online, Table S2 ).
We also used the same experimental design for GWAS analysis. We performed univariate GWAS for CAD by fitting the MLM implemented in GCTA under an additive mode of inheritance. Similar to GREML approach, we included sex and the first 10 principal components as covariates in the model. The genomic inflation of the GWAS results k was 0.98; which indicates lack of population structure and/or genotyping error ( Figure 2B) . Furthermore, the top associated SNPs in our result were within the well-replicated 9p21 region ( Figure 2B) . Finally, we conducted principal component analysis (PCA) of ancestry and mapped our sample with African, European, South Asians, and East Asians population samples from 1000 Genomes Project. As it is depicted in the PCA graph of ancestry (Figure 3) , our cases and controls clustered within the European sample.
Heritability partitioning by chromosomes
To investigate the contribution of each chromosome to the SNP-based heritability (h 2 g =22%), we generated the GRMs based on the SNPs on each autosome and allocated the total heritability onto individual chromosomes by fitting the GRMs of all the chromosomes simultaneously using joint analysis.
The scatter plot of h 2 C (from joint analysis) vs. chromosomal length is presented in Figure 4 . We found that chromosomal length explains 20% (Coefficient of determination or R 2 = 0.2, P = 0.02) of variation in h 2 C ( Figure  4A) . Similar analyses based on SNP proportions, number of proteins and number of genes per chromosomes, respectively explained 18% (P = 0.03), 8 .4% (P = 0.1), and 14.4% (P = 0.05) of h 2 C variation ( Figure 4) . In addition, the correlation of h 2 C with chromosomal length, SNP proportions, and number of genes and proteins were significantly different (P < 0.003) from 1 (H 0 : r = 1) which indicates that the genetic factors underlying CAD are not uniformly spread across the chromosomes. Notably, chromosome 6 contributed less heritability to CAD than expected given its length ( Figure 4 ). This could be because chromosome 6 encompasses the human leucocyte antigens (HLA) locus which is known to have a complex LD structure, and carries many heterogeneous variants. Therefore, we repeated the analysis but partitioned the heritability of chromosome 6 to HLA and non-HLA regions but found that heritability attributed to chromosome 6 remained small after excluding the HLA region (see Supplementary material online, Figure S1 ). We also investigated genetic variance explained by SNPs on the X chromosome (Pseudoautosomal regions were excluded) and found that the ) in all, males, and females and genetic correlation (r g ) between males and females were calculated using Eqs. 4 
Heritability partitioning by pathways/ functional genesets
It is hypothesized that a complex disease has a modular nature, namely it is the result of perturbation in a biological process that produces recognizable developmental and/or physiological abnormalities. 18 Pathway analysis has been developed based on this notion to compensate for the lack of power in traditional GWAS. 18, 19 Available databases differ in terms of coverage and annotation; thus, the outcomes of pathway analysis are not always consistent across different databases. Moreover, there is not yet a consensus as to which database is most suitable for functional analysis of GWAS data. Here, we examined the cumulative heritability of CAD explained by the genesets from the publically available pathway databases including KEGG, BIOCARTA, REACTOME, PID, HALLMARK-MsigDB, Panther, and HumanCyc. To estimate the heritability explained by genes from a database, we took a joint analysis approach, namely, we generated two GRMs, one based SNPs that mapped to the all genes from a database and a second GRM based on the remaining SNPs, with genes defined by 1 Kb boundaries extending from their start and stop positions. Then, we fitted both GRMs in the MLM model and estimated the heritability attributed to the database. This joint analysis approach controls the heritability estimate from being biased upward. 13 Results differed markedly; pathway databases explained from 10 -6 % of CAD risk for BIOCARTA to 6 .2% in REACTOME. Moreover, only pathways in the REACTOME database showed higher heritability beyond that expected by the proportion of SNPs represented ( Figure 5A ) demonstrating that of the databases tested, REACTOME is the most suitable for pathway analysis of high-throughput genomic data of CAD.
We also investigated the contribution of curated genesets from Gene Ontology (GO), Molecular Signatures Database (MsigDB), and Coronary Artery Disease Gene Database (CADgeneDB). The three domains of Gene Ontology including cellular compartment (CC), molecular function (MF), and biological process (BP), respectively explained 4.4, 4.5, and 3.2% of CAD risk thus within the expected range given the proportion of SNPs they encompass ( Figure 5A ). Among the collection of curated genesets from MSigDB, we found that cancer modules (CM) falls outside of the 95% CI and account for more heritability than the proportion of SNPs it represents ( Figure 5A ). Finally, we computed the heritability attributable to genes from CADgeneDB which is a manually curated database of CAD genes. The cumulative contribution of all genesets from CADgeneDB to CAD heritability (h 2 g ) was 7% which is not significant given the proportion of SNPs encompassed ( Figure 5B) . In comparison, CAD loci identified through GWAS studies represented a small proportion of SNPs but explained significant amount (17%) of h 2 g ( Figure  5B ). This indicates manual curation does not necessarily lead to a more pertinent gene list as compared to approaches that systematically search the whole genome.
Next, we repeated the analysis by considering 10, 30, 50, and 100 Kb windows around the genes, as presented in Supplementary material on line, Figure S2 . We found significant enrichment of heritability in the genomic regions around the genes which suggest regulatory regions in or close to genes are enriched in genomic factors that contribute to CAD heritability. In addition, the estimates of variance explained by each pathway/geneset database were linearly related to the proportion of SNPs they represent (coefficient of determination R 2 = 0.92, P = 9.3e -10 , Figure  5A) . A similar pattern was also observed when we considered 10, 30, 50 and 100 Kb windows around the genes (R 2 > _ 0.91, P < _ 1.5e -9 , see Supplementary material online, Figure S3) .
Next, we searched for individual pathways/genesets (modules) within these categories that significantly associated to CAD. We computed the explained heritability and the corresponding P-value for each module and further Bonferroni-corrected the P-value by the number of modules in each category. Larger modules contain more SNPs and are expected to explain larger proportion of heritability. We corrected this, by comparing the proportion of heritability explained by a module to its ) (y-axis) per chromosome was plotted against chromosome length (x-axis); we investigated the effect of population structure (cryptic relatedness and population stratification) by comparing the heritability estimates from the separate (red) and joint REML analysis (blue). Cryptic relatedness and population stratification accounted for 4.8e -4 and 3.3e -6 of phenotypic variance which indicates population structure is appropriately controlled in our database. The dashed line shows the difference between the two models, the intercept of this line indicates the cryptic relatedness with a value close to zero indicates no cryptic relatedness; similarly, the slope indicates the population stratification.
(B) Quantile-quantile plot of P-values from the MLM-based GWAS.
The observed P-values (vertical axis) are plotted against the expected P-values of a null distribution (horizontal axis). The shaded band represents the 95% CI. The genomic inflation (k) was 0.98; which indicates lack of population structure and/or genotyping error. In addition, the top associated SNPs were within the well-replicated CAD locus 9p21. proportion of SNPs and calculated the heritability enrichment P-value using Z-test. We found five modules that showed significant heritability enrichment ( Figure 6A and see Supplementary material online, Table S3 ).
Genes undergo gene-expression regulation in dendritic cells following lipopolysaccharide stimulation
The most significant associated modules included a group of three immune related genesets, namely GSE17721_CTRL_VS_LPS_2H_BMDM _DN, GSE17721_CTRL_VS_LPS_1H_BMDM_UP, and GSE14000_UN STIM_VS_4H_LPS_DC_UP. All three are composed of genes that undergo gene-expression regulation in dendritic cells (DCs) following lipopolysaccharide stimulation and respectively explained 9.5, 6.5 and 5.6% of heritability (h 2 g ) ( Figure 6A and see Supplementary material online, Table S3 ). Since there are only nine shared genes (see Supplementary ma terial online, Table S4 ), we merged these modules and estimated their joint contribution. The three modules collectively explain 19 .5% (SE = 4.3%) of h 
Cell surface interactions at the vascular wall
Genes involved in cell surface interactions at the vascular wall in response to injury explained 5.2% of h 2 g ( Figure 6A and see Supplementary material online, Table S3 ). The 91 genes in this pathway (see Supplementary material online, Table S4 ) describe some of the key interactions that assist in the process of platelet and leukocyte interaction with the endothelium, in response to injury. Further examination of this module revealed that the observed effect is mainly due to a subset of 30 genes (see Supplementary material online, Table S4 ) involved in Basigin interaction (see Supplementary material online, Table S3 ). Basigin also known as extracellular matrix metalloproteinase inducer (EMMPRIN) is a widely expressed transmembrane glycoprotein which belongs to the immunoglobulin superfamily. Basigin is highly enriched on the surface of epithelial cells and has an established role in processes related to atherosclerosis. 20, 21 Cancer module_204
Amongst gene modules that undergo significant gene expression changes in cancer cells, we found a module of 86 genes that explained 5.8% of h 2 g ( Figure 6A and see Supplementary material online, Table S3 ). This CM, identified as Module_204 in MSigDB was initially associated with lung cancer, leukaemia, and B lymphoma. 22 We noted that the identified modules are not completely independent and contain a number of shared genes (see Supplementary material online, Table S4 ). Collectively, the identified modules explained 6% (SE = 0.9%) of liability to CAD (27% of h 2 g , SE = 5%). Four of the identified modules ( Figure 6A) were immune related and inflammation is considered to be fundamental in mediating all stages of atherosclerosis including initiation, progression and, ultimately, thrombotic complications. 6 Thus, we next investigated the contribution of inflammatory response genes from Calvano et al. 23 to the heritability of CAD. As a control experiment, we also investigated the contribution of CNS genes reported by Raychaudhuri et al. 24 The cumulative contribution of all CNS genes to CAD heritability (h 2 g Þ was 5% which was even smaller than the proportion (13%) of SNPs encompassed ( Figure 6B) . In 
Heritability partitioning by SNP annotations
Next, we investigated; whether the heritability of CAD is proportionally spread across the allele frequency spectrum. For this purpose, we allocated SNPs into five MAF-Bins and estimated their joint contribution to heritability. After comparing the proportion of heritability explained by each MAF-Bin to its proportion of SNPs, we did not find any significant difference ( Figure 7A) . This shows the heritability of CAD is proportionally distributed across the allele frequency spectrum. Following this, we partitioned heritability according to SNP type. Forty-three percent of variants in our dataset were genic, residing in exonic, intronic, noncoding transcripts, or regulatory regions near the gene. Genic variants accounted for 62% (SE = 12%) of heritability (h 2 g ) higher (P = 0.03) than non-genic variants that represented 57% of variants but explained only 38% (SE = 12%) of h 2 g ( Figure 7B ).
We further investigated the heritability enrichment by examining 53 'overlapping' annotation categories from Finucane et al. 25 In each category, we compared the proportion of heritability (h 2 g ) explained by the category to its proportion of SNPs and calculated the Bonferronicorrected P-value using Z-test. Our null hypothesis assumes the proportion of heritability attributed to a category is equal to its proportion of SNPs. We found large enrichment of heritability in three categories that mark transcriptionally active regions and are susceptible to epigenetic modification namely, enhancers, H3K9ac/H3K27ac/H3K4me1/ H3K4me3 histone modifications and Fetal DNase I hypersensitivity sites ( Table 2) .
Enhancer elements showed the largest enrichment of any category with 13% of SNPs explaining an estimated 80% (SE = 14%, P = 1.2e -4 for enrichment) of SNP-based heritability (h 2 g ). Enhancer elements were initially generated by processing ENCODE data from six cell lines using chromHMM and Segway algorithms as described by Hoffman et al. 26 Among, histone modification sites, H3K9ac sites showed the highest enrichment of heritability, with 19% of SNPs explaining 80% (SE = 13%, P = 2.3e -4 for enrichment, Table 2 ) of h 2 g . H3K9ac is one of the most characterized epigenetic marks associated with active transcription and 
is highly correlated with active promoters. 27 We also found high-heritability enrichment in H3K27ac sites with 30% of SNPs explaining 87% of h 2 g (SE = 13%, P = 4.5e -3 , Table 2 ), H3K27ac is antagonistic to the repression of gene expression by its counterpart, H3K27me2/3 and it is associated with active transcription. 28 Similarly, H3K4me1 sites represented 41% of the SNPs but explained 99% (SE = 13%, P = 8.0e -4 , Table 2 ) of h 2 g , H3K4me1 is found at both transcriptionally active promoters and distal regulatory elements. 29 Finally, chromatin sites that undergo H3K4me3 explained 92% (SE = 17%) of h 2 g which was considerably higher (P = 2.9e -3 , Table 2 ) than the proportion of SNPs represented (23%). H3K4me3 is considered a hallmark of actively transcribed genes. 29 Fetal DNase I hypersensitivity sites also showed high-heritability enrichment with 27% of SNPs explaining 99% of h 2 g (P = 9e -3 , Table 2 ). DHSs or DNase I hypersensitive sites are regions of chromatin that are sensitive to cleavage by the DNase I enzyme and mark transcriptionally active regions of the genome.
We found high-heritability enrichment in 500-bp flanking regions around these elements, suggesting the boundaries of these functional regions are not well defined or that there are unknown regulatory elements close to them. In contrast to transcriptionally active regions, heritability was highly depleted in transcriptionally repressed regions; repressed regions encompassed 48% of SNPs but explained negligible amount of h 
Genetics of coronary artery disease
between repressed regions and enhancers was minimum ($0% overlap, see Supplementary material online, Figure S4 and 
Discussion
Here in a sample of 7512 unrelated cases/controls, common genomewide variants in autosomal SNPs were found to explain 55% of narrowsense heritability of CAD. In comparison, loci recently identified through GWAS analysis explain about 22% of narrow-sense heritability of CAD. 9 We believe our estimate is still a lower bound for narrow-sense heritability due to imperfect linkage disequilibrium between causal variants and examined SNPs exacerbated by causal variants having lower MAF. Therefore, as higher density genotyping arrays with better coverage for lower frequency variants become available and sample size of GWAS studies increase, it is expected that more individual SNP associations will be detected for CAD and genome-wide variants collectively explain a larger portion of CAD narrow-sense heritability.
We did not detect significant genetic difference in liability to CAD between males and females which indicates that the majority of common variants that contribute to CAD heritability are shared between sexes. Consistently, two recent GWAS studies from the CARDIOGRAM Consortium based on autosomal chromosomes and on the X-chromosome did not identify variants with sex-different effects. 9, 30 Of interest genetic factors underlying CAD did not uniformly spread across the genome proportional to chromosomal lengths. This phenomenon has been also observed for BMI and Alzheimer disease 13, 31 but not, for other traits including human height and schizophrenia, where estimates of heritabilities by chromosomes was highly correlated with chromosomal length.
11,16
The failure to detect differences in heritability enrichment for CAD between MAF-Bins is expected given that in general the age of onset of CAD is after reproductive years and thus reduced fertility and fecundity associated with early onset diseases does not generate differences in the frequency distribution of risk alleles for CAD. In this regard, a recent 1000 genomes-based GWAS meta-analysis of $185 000 CAD cases and controls from the CARDIOGRAMplusC4D Consortium also found that susceptibility to CAD is largely determined by common SNPs of small effect size. 9 In recent years, pathway-based analysis of GWAS data has emerged to address the lack of power in GWAS and to elucidate the molecular mechanisms underlying a complex disease. 18, 19 Our REML analysis showed that even the most current pathway databases do not have comprehensive coverage of the biological processes underlying CAD pathogenesis. Nonetheless, we found that among the publically available pathway databases, REACTOME provides a better coverage of the biological process underlying CAD and therefore, is more suitable for pathway analysis of high-throughput genomic data of CAD. Moreover, by testing individual modules, we found a number of biological processes that are significantly associated with CAD. Stimulation of DCs showed the strongest association with CAD. We found three independent genesets that undergo gene-expression regulation in stimulated DCs. This finding further underscores the regulatory role of DCs in cardiovascular disease. 32, 33 DCs have a close relationship to endothelial cells and they interact with each other to maintain immunity. They are deposited in the atherosclerotic plaque and contribute to the pathogenesis of atherosclerosis, and in this regard, DC immunotherapy has been considered for treatment of atherosclerosis. 32, 33 Genes involved in Basigin interactions within the cell surface interactions at the vascular wall also showed significant heritability enrichment. Basigin, also known as extracellular matrix metalloproteinase inducer (EMMPRIN) or CD147 is a widely expressed transmembrane glycoprotein which belongs to the immunoglobulin superfamily and is highly enriched on the surface of endothelial cells. EMMPRIN is induced upon monocyte differentiation and is expressed in human atheroma. 21 EMMPRIN has a number of roles related to atherogenesis including induction of angiogenesis via stimulation of VEGF production, disruption of nitric oxide metabolism and activation of Rho/Rho-kinase, 34, 35 proinflammatory effects, and vascular smooth muscle cell proliferation. 20 Finally, consistent with the hypothesis that cell proliferation is an important feature of atherosclerosis. 36 We found a CM previously reported for several types of cancer to be significantly associated with CAD.
Excluding the CM, the remaining modules were immune related. Inflammation is considered to be fundamental in mediating all stages of atherosclerosis pathogenesis including initiation, progression and ultimately, thrombotic complications. 6 Consistent with this concept, we also found that genes involved in the inflammatory response explain a significant amount of CAD heritability. This further supports the notion that inflammation promotes atherosclerosis and is not merely a consequence of atherogenic processes. 4, 6 Epigenetics alterations have been recognized as important mediators in the pathogenesis of various complex diseases, including CAD. 4, 37, 38 In addition to environment, genetic factors contribute to inter-individual variation in gene expression to the extent that they alter susceptibility to epigenetic modifications and it has been reported that variation in epigenetic patterns can be explained by common SNPs. 38 In this study, we found that SNPs in epigenetic sites associated with transcriptional activity including enhancers, H3K9ac/H3K27ac/H3K4me1/H3K4me3 histone modifications and Fetal DNase I hypersensitivity sites explain a large portion of CAD heritability. Of note, Maurano et al. 39 reported that common disease-associated variants are concentrated in DNase I hypersensitive sites (DHSs) and 88% of such DHSs are active during foetal development. It is also documented that the prodromal stages of human atherosclerotic lesions are already set during foetal development and prenatal epigenetic modifications have been implicated in atherosclerosis. 4, 5 In addition, there is ample evidence that histone modifications have a relevant role in inflammation, smooth muscle cell proliferation, and extracellular matrix remodelling, all processes that are central to atherogenesis. 4, 5 A number of studies have been shown that polymorphisms that change amino acid sequence are quantitatively not a major player in complex disease pathogenesis, and variation in gene expression is generally a more important mechanism underlying susceptibility to common complex disease. 40 As expected, we also found that the heritability explained by the synonymous variants in our study was not significantly different as compared to non-synonymous variants. Nonetheless, it is important to underline that our analysis was based common variants only and rare variants could show different pattern. Examples of these for CAD are rare coding variants in genes regulating lipoprotein metabolism. 8 In summary, the importance of DNA variation in sites susceptible to epigenetic modification is known in complex disease. 38, 39 In this study,
we provide a quantification of this contribution to CAD heritability. Since repressed regions cover about 50% of the genome and do not contribute to CAD risk, these findings will assist in the design of specific and comprehensive custom sequencing or genotyping panels, focused on variants in transcriptionally active regions. 41, 42 Furthermore, this study demonstrates that one can quantify the contribution of a pathway/ geneset to a disease pathogenesis without focusing on individual SNPs or setting a significance threshold. Golan et al. 43 reported that the heritability estimate using GREML approach is underestimated in case-control design particularly when the prevalence of disease is low (K < 0.01) and introduced a phenotype correlation-genotype correlation (PCGC) regression approach to address this issue. Here, we estimated the heritability using PCGC regression software (latest version, 2014) and found that the heritability estimate (h 2 g = 0.18) was even lower than the estimated heritability from the GREML approach (h 2 g = 0.22) implemented in GCTA. This could be because CAD is a very common disease (K = 0.06) and the underlying assumption in PCGC software that SNPs are in linkage equilibrium (independent) 43, 44 cannot be undertaken in our dataset of 3 163 082
SNPs.
It is unlikely that the observed associations are due to confounding or reverse causation. This is because the genotype of a person for a trait is randomly determined through the meiosis (Mendelian randomization). As such, the current work mimics the design of a randomized control trial and the observed associations between the genotypes and CAD are immune to confounding environmental factors or reverse causation. 38, 45 Furthermore, it is also unlikely that population stratification or cryptic relatedness could cause the observed effects, as we took extra care to address them.
It is important to emphasize that our MLM model estimates the cumulative contribution of SNPs to CAD heritability. To identify the causal variants in regions that show significant heritability enrichment, it is important to conduct univariate association analysis. Such a joint approach allows combining the merits of both methods and also reduces the number of tests in Bonferroni correction.
In summary, we have investigated the genetic structure of CAD using over three million genome-wide SNPs (MAF > _ 0.01) and MLMs in a sample of genetically unrelated 7512 cases and controls and report that genome-wide SNPs explain 22% of liability to CAD (55% of narrowsense heritability). We show that sex differences in CAD are not due to common SNPs and the estimated SNP-based heritability is proportionally spread across the allele frequency spectrum and notably enriched among genic SNPs. We identify a number of modules that are significantly associated with CAD including DCs stimulation; Basigin interactions, and a CM. The identified modules provide further biological insight into the pathogenesis of CAD and highlight the importance of immunemediated processes. Finally, in accord with other reports for complex diseases, we find that genetic liability to CAD is mainly due to polymorphisms within transcriptionally active regions.
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